896472-89-2

Upstream product

• 896472-83-6 ethyl 4-(4-(2-(5-acetylamino-2,2-dimethyl-1,3-dioxan-5-yl)ethyl)phenyl)butanoate 
• 896472-84-7 N-(5-(2-(4-(4-hydroxybutyl)phenyl)ethyl)-2,2-dimethyl-1,3-dioxan-5-yl)ethanamide 
• 896472-86-9 ethyl 8-(4-(2-(5-acetylamino-2,2-dimethyl-1,3-dioxan-5-yl)ethyl)phenyl)octanoate 
• 896472-85-8 N-(2,2-dimethyl-5-(2-(4-(4-oxobutyl)phenyl)ethyl)-1,3-dioxan-5-yl)ethanamide 
• 896472-87-0 N-(5-(2-(4-(8-hydroxyoctyl)phenyl)ethyl)-2,2-dimethyl-1,3-dioxan-5-yl)ethanamide 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 896472-91-6 S-(8-(4-(2-(5-acetylamino-2,2-dimethyl-1,3-dioxan-5-yl)ethyl)phenyl)octyl)ethanethioate 

Relevant academic research and scientific papers

Preparation of antibodies against a novel immunosuppressant, FTY720, and development of an enzyme immunoassay for FTY720

FTY720 (1) is a novel immunosuppressant (immunomodulator), derived from ISP-I (2: myriocin and thermozymocidin). To clarify the pharmacokinetic properties of 1, antibodies against 1 were prepared and a competitive enzyme immunoassay (EIA) was developed. T